Tourette syndrome is a neurological condition that has no cure but can be managed with various strategies—some of which are ...
Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...
1d
GlobalData on MSNRelmada acquires Tourette’s therapy rights from AsarinaRelmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.
WXYZ Detroit 7, MI on MSN1d
Teacher with Tourette syndrome uses his disability as an inspiration for studentsThere's a big stigma surrounding Tourette syndrome and other brain disorders, but Milan teacher Larry Biederman is working to break that by showing his students how they can be successful despite ...
1don MSN
In PEOPLE's exclusive sneak peek at an upcoming episode of TLC's 'Baylen Out Loud', Baylen decides to try Botox for the first ...
12don MSN
Baylen Dupree, 22, stars in a new TLC series after she built a following on social media. She wants people to know what it's ...
Tourette syndrome is currently diagnosed about three times more frequently in males than in females. A new study finds that female individuals are less likely to be diagnosed with the syndrome, take ...
Baylen Out Loud star Baylen Dupree is taking a major step with boyfriend Colin Dooley. The 22-year-old influencer was ...
US CNS specialist Relmada Therapeutics has announced the acquisition of sepranolone, a Phase IIb ready neurosteroid, from ...
13d
Digital Camera World on MSNHelp! I think I have photography Tourette's!Things are absolutely tickety-boo when I’m the one taking the shot. I compose carefully to ensure there’s no unnecessary ...
Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...
Relmada Therapeutics (RLMD) announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid, from Asarina Pharma AB, being developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results